Bottom line
What is AISBX's expense ratio?
AISBX's expense ratio is 1.91%, or about $191 a year on every $10,000 invested. That is more expensive than 92% of small-cap funds we track (median 0.99%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Aug 3, 2026
AISBX fee table
| Net expense ratio | 1.91% |
|---|---|
| Gross expense ratio | 1.9% |
| Management fee | 0.9% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.01% |
| Fee waiver / reimbursement | 0% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Aug 3, 2026
What AISBX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| AISBX | $293 | $597 | $1,026 | $2,222 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.91% expense ratio costs roughly $97,800 in lost growth, versus about $54,900 for the median small-cap fund (0.99%).